Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$78.22 - $90.4 $54,206 - $62,647
-693 Reduced 10.99%
5,613 $439,000
Q2 2023

Jul 19, 2023

BUY
$79.47 - $91.38 $144,873 - $166,585
1,823 Added 40.66%
6,306 $555,000
Q1 2023

Apr 25, 2023

SELL
$76.72 - $87.58 $36,518 - $41,688
-476 Reduced 9.6%
4,483 $361,000
Q4 2022

Jan 24, 2023

BUY
$76.18 - $87.74 $23,463 - $27,023
308 Added 6.62%
4,959 $0
Q3 2022

Nov 03, 2022

SELL
$80.75 - $95.31 $245,399 - $289,647
-3,039 Reduced 39.52%
4,651 $376,000
Q2 2022

Aug 09, 2022

BUY
$87.4 - $113.09 $23,335 - $30,195
267 Added 3.6%
7,690 $690,000
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $465,081 - $519,645
-4,624 Reduced 38.38%
7,423 $824,000
Q3 2021

Oct 25, 2021

BUY
$122.75 - $135.17 $513,095 - $565,010
4,180 Added 53.13%
12,047 $1.51 Million
Q2 2021

Aug 13, 2021

SELL
$118.19 - $131.5 $416,619 - $463,537
-3,525 Reduced 30.94%
7,867 $976,000
Q1 2021

May 17, 2021

BUY
$111.18 - $119.74 $339,432 - $365,566
3,053 Added 36.61%
11,392 $1.35 Million
Q4 2020

Feb 18, 2021

BUY
$100.57 - $117.14 $41,334 - $48,144
411 Added 5.18%
8,339 $977,000
Q3 2020

Nov 23, 2020

SELL
$90.13 - $108.78 $188,011 - $226,915
-2,086 Reduced 20.83%
7,928 $824,000
Q3 2020

Nov 16, 2020

BUY
$90.13 - $108.78 $263,179 - $317,637
2,920 Added 41.16%
10,014 $944,000
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $56,101 - $68,921
-667 Reduced 8.59%
7,094 $651,000
Q1 2020

May 05, 2020

BUY
$72.92 - $121.3 $75,618 - $125,788
1,037 Added 15.42%
7,761 $700,000
Q4 2019

May 05, 2020

BUY
$104.49 - $114.54 $702,590 - $770,166
6,724 New
6,724 $763,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.